PD173074

For research use only.

Licensed by Pfizer Catalog No.S1264

97 publications

PD173074 Chemical Structure

CAS No. 219580-11-7

PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM in cell-free assays, ~1000-fold selective for FGFR1 than PDGFR and c-Src. PD173074 reduces proliferation and promotes apoptosis in gastric cancer cells.

Selleck's PD173074 has been cited by 97 publications

Purity & Quality Control

Choose Selective FGFR Inhibitors

Biological Activity

Description PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM in cell-free assays, ~1000-fold selective for FGFR1 than PDGFR and c-Src. PD173074 reduces proliferation and promotes apoptosis in gastric cancer cells.
Targets
FGFR1 [1]
(Cell-free assay)
VEGFR2 [1]
(Cell-free assay)
~25 nM 100 nM-200 nM
In vitro

PD173074 is an ATP-competitive inhibitor of FGFR1 with Ki of ~40 nM. PD173074 is also an effective inhibitor of VEGFR2. Compared to FGFR1, PD173074 weakly inhibits the activities of Src, InsR, EGFR, PDGFR, MEK, and PKC with 1000-fold or greater IC50 values. PD173074 inhibits autophosphorylation of FGFR1 and VEGFR2 in a dose-dependent manner with IC50 of 1-5 nM and 100-200 nM, respectively. [1] PD173074 inhibits FGF-2 promotion of granule neuron survival in a dose-dependent manner with IC50 of 12 nM, exhibiting 1,000-fold greater potency than that of SU 5402. [2] PD173074 specifically inhibits FGF-2-mediated effects on proliferation, differentiation, and MAPK activation in oligodendrocyte (OL) lineage cells. [3] PD173074 is active against the WT receptor and FGFR3 mutations in multiple myeloma (MM) cell lines. PD173074 also potently inhibits autophosphorylation of FGFR3 in a dose-dependent manner with IC50 of ~5 nM. PD173074 treatment potently reduces viability of FGFR3-expressing KMS11 and KMS18 cells with IC50 of <20 nM. Inhibition of aFGF-stimulated MM cell growth by PD173074 is highly correlated with the expression of FGFR3. PD173074 treatment completely abolishes NIH 3T3 transformation mediated by Y373C FGFR3 but not by Ras V12, demonstrating that PD173074 specifically targets FGFR3-mediated cell transformation and lacks nonspecific cytotoxic effect. PD173074 also induces functional maturation of KMS11 and KMS18 cells. [4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
NCI-H1581 M4e5Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmLhTWM2OD1yLkCxNlI2KM7:TR?= MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
KG-1 M3vsSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVLJR|UxRTBwMEWxNlkh|ryP M1\teFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
MFM-223 M2rpOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUXJR|UxRTBwMkG1O|Yh|ryP NV7MTmZkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
EoL-1-cell NGi0[Y9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2fTcGlEPTB;MD6zNlk5PCEQvF2= NHvxWFU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
ECC10 NHLsUoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF2zfllKSzVyPUCuN|M5QThizszN MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
H-EMC-SS MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWXxPVE2UUN3ME2wMlM1PzF3IN88US=> MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
AN3-CA MlP6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEDCc2dKSzVyPUCuOFAyOzNizszN MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
HuO-3N1 MknXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3T4dmlEPTB;MD61OFY2OyEQvF2= NGDFXpc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
RT-112 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2jWNmlEPTB;MD61OFcxOSEQvF2= Mk\oQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
NEC8 MkTMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlrkTWM2OD1yLkW2Nlg6KM7:TR?= NHHiW4w9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
D-263MG NHjueY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnzzTWM2OD1yLkexNVU6KM7:TR?= M{nXc|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
SW962 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnT3TWM2OD1yLke4PVg5KM7:TR?= M2TBfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
BV-173 MlfMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUTJR|UxRTBwOES2NlMh|ryP MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
MFE-280 M2PNOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX[xNoU4UUN3ME2wMlg2QDd{IN88US=> NYnheJlwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
HuH-7 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlfrTWM2OD1zLkK0OFY1KM7:TR?= MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
RS4-11 NILjXlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2j0O2lEPTB;MT6zN|g5PiEQvF2= NInySpI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
DMS-114 NUnTeXFTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{L1S2lEPTB;MT6zOlc{PyEQvF2= MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
MSTO-211H NYr1RmZJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUXEdYZOUUN3ME2xMlQ4Ozd6IN88US=> MlzJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
DU-145 M{TXZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXfscYNmUUN3ME2xMlU5OjF5IN88US=> NIXlOpo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
A172 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4fyeGlEPTB;MT63NFM2PSEQvF2= MmDBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
SBC-1 M2fwemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlS0TWM2OD1{LkC5OEDPxE1? MnHiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
H9 NHfybI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVnJR|UxRTJwMUSzNFYh|ryP NFjDUYM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NCI-SNU-1 NXfFNnZ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV;JR|UxRTJwMUizPVQh|ryP NWLO[2VjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
NCI-H720 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXfJR|UxRTJwMkGyPFMh|ryP NIPFXVk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
HCC2218 MkjBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWjJR|UxRTJwM{e5N|kh|ryP NGPRO2s9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
G-401 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml[2TWM2OD1{LkS3NVg6KM7:TR?= MoLpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
MPP-89 NUL2Om1pT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGnCb3pKSzVyPUKuOFg{PjRizszN NFu2VIg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
697 M{GxUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NE\rSnpKSzVyPUKuOlU{OzFizszN M3LFT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
KARPAS-45 MoLYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1zpXmlEPTB;Mj63NFc1PyEQvF2= M{H4eFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
MG-63 NUGwUoFjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGTzZlNKSzVyPUKuPVQzPjJizszN NGTYPIQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NTERA-S-cl-D1 M33DSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFj2WYNKSzVyPUOuNFM1PzJizszN NID5RXY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
G-402 NV;xNXZnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M37NbGlEPTB;Mz6xNlczPyEQvF2= NHXwcZA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NKM-1 NUPkdFRmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3fwdWlEPTB;Mz6xN|U3PCEQvF2= MoTrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
RH-18 MonjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnvxTWM2OD1|LkG5OVk5KM7:TR?= NET0Olk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NCI-H1092 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXzNdFR1UUN3ME2zMlE6PjlizszN NYP5W5lJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
RPMI-8226 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEi2OVFKSzVyPUOuNlM1PDdizszN NG\GUHI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
GAMG MmP1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYfJR|UxRTNwNE[1O|Yh|ryP NYfFWXVHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
HH MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M17GdWlEPTB;Mz60O|Y4PiEQvF2= MoW0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
RO82-W-1 NXe5bIFzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3\xUWlEPTB;Mz60PVg2PSEQvF2= NWLpSmV4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
CCRF-CEM MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEjKfW9KSzVyPUOuOVA1QDhizszN NEnoXIo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NBsusSR M1nNT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHO5WIFKSzVyPUOuOlM6PjlizszN MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
CHL-1 MmS3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1[2bGlEPTB;Mz62OVc6QSEQvF2= NGrlZY49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
LK-2 M2jWbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mor5TWM2OD1|Lk[3NVM{KM7:TR?= M4\rdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
Hs-578-T MmS5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlvHTWM2OD1|Lk[3PFc{KM7:TR?= MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
CTB-1 NYnhUW85T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MojJTWM2OD1|LkiwNFUyKM7:TR?= MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
ES5 NEf3NIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4OzbGlEPTB;Mz64N|Y{PyEQvF2= MoTjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
A204 M3rkfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NG\6coNKSzVyPUOuPVIxPzVizszN MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
SW780 NVXjWZQzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHXreldKSzVyPUOuPVIzPDVizszN NV3YS5RORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
EW-3 NHLnOG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3;Tb2lEPTB;Mz65PFkzOyEQvF2= NFTYSFc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
A704 NYDXd2hqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MorXTWM2OD12LkK4O|I{KM7:TR?= MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
LU-139 NInxRlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHHEcJJKSzVyPUSuN|E2OzRizszN NHHTVFM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
CAL-72 NV3udo1NT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoHSTWM2OD12LkSxO|Q3KM7:TR?= MonnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
D-336MG NHnY[2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGnIUWNKSzVyPUSuOFY5OTdizszN NFfMXXc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
LAMA-84 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUTJR|UxRTRwNUOzNUDPxE1? NVi5NVNxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
GI-ME-N M1fIfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYLEOlRbUUN3ME20MlU1QDFizszN NUj1PZozRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
KM-H2 MnPTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4nCe2lEPTB;ND61OVIzOiEQvF2= NHnxbXY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NCI-H209 NWf5U2plT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2\PS2lEPTB;ND61PFI5OyEQvF2= MniyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
IGROV-1 NFnwT|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnzzTWM2OD12Lki3NVY5KM7:TR?= MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
L-363 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3LndmlEPTB;ND65OlY3PSEQvF2= MnHhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
SK-MEL-3 NV\VTFdKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVPrNYQxUUN3ME21MlI1ODZizszN MnW4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
HuO9 MoDXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M17JSWlEPTB;NT6zPFg1OyEQvF2= M33id|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
NOS-1 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2DofGlEPTB;NT63NlkzPyEQvF2= MmO1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
NCI-H1770 NIXDOIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXLJR|UxRTVwOUWwN|Ih|ryP M{nQdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
SF126 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmTuTWM2OD14LkKxOFA3KM7:TR?= M2DqXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
ML-2 NGTPU4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnjuTWM2OD14LkK0PVc4KM7:TR?= MonZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
CHP-134 MmL6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV\ndpdiUUN3ME22MlI2OTh{IN88US=> NFTzS4E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NCI-H1355 NX\oUYZOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4LzU2lEPTB;Nj60NVc{OyEQvF2= MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
TE-12 Mlz5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHPZPZRKSzVyPU[uO|I3PzFizszN NH3Zb4U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
A4-Fuk MlP5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWPJR|UxRTZwN{OxOFIh|ryP NYX3Vo9ORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
MV-4-11 M2DaeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3X5bWlEPTB;Nj63OlYzPiEQvF2= MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
SK-UT-1 M3O5[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUXwPGU1UUN3ME22MlkyPzh2IN88US=> NXLqR5lLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
J-RT3-T3-5 NXv1b|FDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEi3XVdKSzVyPUeuNFc4PjRizszN NXG3ZXFNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
ME-180 M{C2dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlfUTWM2OD15LkGwOFA1KM7:TR?= MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
SK-MEL-28 NI\BZm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIizSJVKSzVyPUeuN|c5OTlizszN NWDQV2ZkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
HAL-01 M4jlTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1;FSGlEPTB;Nz60PFM1OSEQvF2= NHnPNoo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
ES8 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2noWWlEPTB;Nz62PVYzPiEQvF2= MoXWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
DB M4ru[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUfJR|UxRThwMUG1NFQh|ryP MlL1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
SK-NEP-1 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXna[JFGUUN3ME24MlQ5OTR7IN88US=> NYTm[WJqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
COR-L88 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX7tNldtUUN3ME24MlUxQThzIN88US=> NVLxbY5oRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
LB1047-RCC MlPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWTJR|UxRThwNUKyNVIh|ryP MkLPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
NCI-H520 NUDNNXBZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGjyeWFKSzVyPUiuOlIyPTdizszN M4HhTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
SW954 NYLhTVZwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1;QdmlEPTB;OD62PVc5PiEQvF2= MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
TE-6 NYXMWJE2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHvLcoRKSzVyPUiuO|UyPDNizszN MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
D-283MED M{CzWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWTlXFR2UUN3ME25MlA3PTN2IN88US=> MnPJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
DBTRG-05MG NVrpZoE3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXf1[VdWUUN3ME25MlA6PjB5IN88US=> MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
NCI-H446 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF;Xc5ZKSzVyPUmuNlk2OjZizszN MnnwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
HOS NX;BR21zT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVXJR|UxRTlwM{WxN|Qh|ryP NUD5Vpc3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
ES4 M{TVdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NW\GbYp{UUN3ME25MlUxPTl3IN88US=> NHvZRo09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
EW-13 NFPudGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVjtO4NyUUN3ME25Mlg6ODV3IN88US=> M1jT[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
IST-MES1 M{jqWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWHJR|UxRTlwOUS1N|Qh|ryP MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
CAS-1 MlH6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlrnTWM2OD17Lkm3OlU6KM7:TR?= NYT4VIpbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
EM-2 Mn7FS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWLJR|UxRTFyLkGzPVMh|ryP MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
SW948 MoXwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXnJR|UxRTFyLkG4PFIh|ryP NI\JeJE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
OAW-42 NWXpUlY1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlywTWM2OD1zMD61NlY4KM7:TR?= MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
BE-13 M1rVWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mmj0TWM2OD1zMD62OVc3KM7:TR?= Mn:3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
KU812 MofwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVTJR|UxRTFyLkezPVEh|ryP M3zrd|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
SK-MEL-30 MlTsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1[yNWlEPTB;MUCuPFkxOSEQvF2= MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
A2780 M3;IRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2K3fGlEPTB;MUGuNFMxQCEQvF2= MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
TGBC24TKB MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2jwfWlEPTB;MUGuNFc{PyEQvF2= MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
GOTO NU\BVVZsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlTCTWM2OD1zMT6yNFg1KM7:TR?= MoXRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
NCI-H526 MkTCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFSzSWVKSzVyPUGxMlM5OzdizszN NITjUXE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
BHT-101 MnT3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWjJR|UxRTFzLkS0OVYh|ryP NH3Obos9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NCI-H1155 Mn;qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYfJR|UxRTFzLkS5OFch|ryP NFHNVHU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
MCF7 Ml3WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIfafGNKSzVyPUGxMlYyPjdizszN MkHVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
MKN45 M1v1T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2XqOmlEPTB;MUGuO|k6OyEQvF2= MlrXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
MOLT-16 NH;yTJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NULmflREUUN3ME2xNU46Pjl{IN88US=> MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
YH-13 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGXBZ3ZKSzVyPUGyMlA{PDZizszN M2rXTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
P12-ICHIKAWA NI\NTGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXvJR|UxRTF{LkO4OFUh|ryP NXHvW3pIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
GR-ST NHzLVJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXHkeZZRUUN3ME2xNk42Ojl3IN88US=> MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
CAKI-1 NH7SPIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHzHWmlKSzVyPUGyMlc6OSEQvF2= M3\3R|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
LXF-289 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2fFRmlEPTB;MUOuNFg{PSEQvF2= NUn4WJp{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
MHH-PREB-1 M{nyRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEPvU3BKSzVyPUGzMlI4ODRizszN NXzCOItoRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
EW-16 NXHC[ZlHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYLTPVh7UUN3ME2xN{4{OTh5IN88US=> MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
NCI-H82 MmjVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYDle|R7UUN3ME2xN{41OTl3IN88US=> MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
MMAC-SF M2XT[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoDqTWM2OD1zMz60OVQ4KM7:TR?= MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
COLO-684 NFnGNGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVrRO4s6UUN3ME2xN{42OzF6IN88US=> MoezQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
QIMR-WIL M4\ZVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkfJTWM2OD1zMz64NVA6KM7:TR?= MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
NB69 MlG4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYfJR|UxRTF|Lkm4Olgh|ryP MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
NCI-H2291 NH\oc25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEnCfJBKSzVyPUG0MlQ1PTNizszN NHHyPXA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
MKN7 MkfvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml;RTWM2OD1zND62Olc3KM7:TR?= NWrwNYRLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
HDLM-2 M33TfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mon5TWM2OD1zNT6xNlg3KM7:TR?= MmjRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
A253 NIqwc2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVfJR|UxRTF3LkO4Olkh|ryP MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
SK-LU-1 M4nYSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXrJR|UxRTF3LkmwPVQh|ryP M2S1fVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
MEG-01 M{jzfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmTjTWM2OD1zNT65NVA4KM7:TR?= NUDRT4lDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
SK-N-DZ NWPEOWpUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUPJR|UxRTF3LkmzO|Yh|ryP NYXuNnpmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
H4 NHPSZo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlmxTWM2OD1zNj6wPFgh|ryP M1HON|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
LU-65 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmK0TWM2OD1zNj6zN|g1KM7:TR?= NHrocWQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NCI-H1048 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIC3[ZJKSzVyPUG2MlUyPjVizszN NEDzRXc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
LCLC-97TM1 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1rWcGlEPTB;MU[uOVg5QSEQvF2= MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
CAL-120 MkK2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnLqTWM2OD1zNj65PFc6KM7:TR?= MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
LU-134-A NUSwOFhZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWLsS2N[UUN3ME2xO{4{OzlzIN88US=> Mn7qQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
SK-MEL-1 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MofCTWM2OD1zNz63NVI4KM7:TR?= NHXW[Jo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NCI-H69 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlrGTWM2OD1zNz65N|A4KM7:TR?= M{PVZ|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
MC116 M17jTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV\JR|UxRTF5Lkm3OUDPxE1? MmTQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
UMC-11 NWXXSlVKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1fFV2lEPTB;MUiuNVc5QCEQvF2= MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
HCC1395 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmjWTWM2OD1zOD60N|AyKM7:TR?= MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
no-10 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmfPTWM2OD1zOD62N|g5KM7:TR?= MoO0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
NY Ml:0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mlm2TWM2OD1zOT6wPFA6KM7:TR?= MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
OS-RC-2 NUjvOFVQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3:3bWlEPTB;MUmuNVI2OiEQvF2= M{S2TlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
D-423MG NWLRXndKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIT1bZJKSzVyPUG5MlM6PTJizszN M2HWeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
LC-2-ad NHyxRVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkHsTWM2OD1zOT63OlEzKM7:TR?= M3PDeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
DU-4475 NWjSbXQ6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVzzdGxKUUN3ME2xPU45QDV{IN88US=> MnSxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
YKG-1 M2n4SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1G1OWlEPTB;MUmuPVYzKM7:TR?= NGf1SJQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
HCC1569 MnThS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYrYcldCUUN3ME2yNE4zPjJ2IN88US=> NGG4S3Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
TYK-nu NIfQOYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIHXRnpKSzVyPUKwMlI5PDdizszN NX\Xc|JMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
DEL MnH2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{n1ZWlEPTB;MkCuPVgxQCEQvF2= NWPSeJo4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
MHH-ES-1 M1LncGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXjJR|UxRTJzLkO1PVch|ryP NH;mXZE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
KARPAS-299 MnPoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIj4OVNKSzVyPUKxMlUzQSEQvF2= M1;YN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
CTV-1 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXf3OVd6UUN3ME2yNU43OTd{IN88US=> MmjNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
NCI-H2452 NIX2R4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFvqfVZKSzVyPUKyMlY3PzdizszN NILrSms9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
D-566MG NYexRYlsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn;pTWM2OD1{Mj63OlAyKM7:TR?= MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
EFO-27 NHfyZ3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXLJR|UxRTJ|LkC2OVEh|ryP MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
NCI-H596 NXPQ[mZ[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHT1TolKSzVyPUKzMlg2OjdizszN NEO5OIE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
KS-1 M3zTSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{\1SGlEPTB;MkSuNlc2QSEQvF2= MlHsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
8305C NEDzfXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYDJR|UxRTJ2LkSwOFUh|ryP MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
A427 NYTUfY0xT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHjZZoFKSzVyPUK1MlA{OjNizszN M1rqeVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
COLO-800 NYX5OncyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVT1VoVFUUN3ME2yOU4yODZzIN88US=> MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
SJRH30 M37JNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkDZTWM2OD1{NT6zPVA5KM7:TR?= NXXlbIluRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
MEL-HO MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIftTldKSzVyPUK1MlQ{OTlizszN NWr6eFR{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
FTC-133 NXrzb|VrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlrCTWM2OD1{NT64NVg3KM7:TR?= Ml23QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
SF295 NHXhTZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4HXWmlEPTB;Mk[uNlk3KM7:TR?= MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
SW1710 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2Xob2lEPTB;Mk[uOFEzOyEQvF2= NUXnTFZ2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
EFM-19 NIqyVnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUfud2FrUUN3ME2yOk45OTR3IN88US=> MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
NB10 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXfJeYJQUUN3ME2yPE4zOjl5IN88US=> M17kRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
TK10 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYm2XJNkUUN3ME2yPE4zOzl7IN88US=> Mnm4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
D-502MG Mo\qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWDJR|UxRTJ6LkSg{txO M2TGWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
EW-18 M{nOfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3THT2lEPTB;MkiuOFM5PiEQvF2= MoLjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
VMRC-RCZ MkG3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlGzTWM2OD1{OD65OFEh|ryP NX;aSG9VRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
Ca9-22 NWjDSlJGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml;rTWM2OD1{OT60OVU4KM7:TR?= NILCZZU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
KYSE-70 M3Tm[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4TyOGlEPTB;MkmuOVc5PiEQvF2= MnT6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
A101D M{Xzc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFvyV|BKSzVyPUK5MlY1PzJizszN M33qc|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
WM-115 NHfNeJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUTJR|UxRTJ7Lke2NFch|ryP M{TCWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
HCC2157 MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVjMWWdZUUN3ME2yPU45QDB5IN88US=> MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
TE-9 M1H6TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFOwcFhKSzVyPUK5Mlg5PjVizszN M4jtSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
K-562 NFzBW2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnHHTWM2OD1|MD6wPVM{KM7:TR?= M3LNfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
SN12C NYTwb2dFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3ey[mlEPTB;M{CuNVQzPiEQvF2= MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
ESS-1 NXLFTG4{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmDZTWM2OD1|MD60O|U6KM7:TR?= Ml2zQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
K5 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH;IeVdKSzVyPUOwMlc3PCEQvF2= M{TRUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
J82 MmTYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUPJ[HhNUUN3ME2zNU4xQDl5IN88US=> NEXGOXc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
HOP-92 NF7OcpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3;3VGlEPTB;M{GuNVEyOSEQvF2= NICwS|Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NCI-H2228 NID1UXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUHuXYtRUUN3ME2zNU4{Ojl4IN88US=> M{X6WFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
OCI-AML2 NXy1dFJuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGjtWG1KSzVyPUOxMlM3OSEQvF2= NEXDOGw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NCI-SNU-5 M2HvOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVPJR|UxRTNzLkixN|ch|ryP MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
A3-KAW MkDBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4f5cmlEPTB;M{GuPVI1OyEQvF2= NHzu[GM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
LCLC-103H NUfySXdNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV\YdIJyUUN3ME2zNk4xOTdzIN88US=> MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
KY821 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3TNNGlEPTB;M{KuOlg5PCEQvF2= NFXY[5Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
JVM-2 Mor1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlH2TWM2OD1|Mj65NFc6KM7:TR?= NGTJbYI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
Mo-T NXXEb2tpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHfFUYtKSzVyPUOzMlExODVizszN M1jzXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
IA-LM MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnW1TWM2OD1|Mz6yO|Uh|ryP M4\lelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
C8166 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{DVbWlEPTB;M{OuN|E6OiEQvF2= MkD3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
TCCSUP M1zUSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnrXTWM2OD1|Mz60N|A4KM7:TR?= MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
JEG-3 NFHYfm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnfhTWM2OD1|Mz60O|Y5KM7:TR?= MknSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
MS-1 MlfPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2q0c2lEPTB;M{OuOVU2OSEQvF2= NFXX[5g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NCI-H1304 MnPzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{LrN2lEPTB;M{OuOVczPSEQvF2= MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
Ramos-2G6-4C10 Ml;CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NG[x[YZKSzVyPUO0MlA{OzVizszN MlrrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
MDA-MB-453 NVLnTGlsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUTJR|UxRTN2Lk[zPVUh|ryP NXLjNWN4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
KYSE-520 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUXJR|UxRTN2LkexPFEh|ryP MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
SW900 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4SxSWlEPTB;M{SuPFEyPSEQvF2= NFvtfGw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
HCC2998 M2rR[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmnYTWM2OD1|NT6xOVI6KM7:TR?= NXTCV4I6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
A2058 M3XqUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmPTTWM2OD1|NT62NFYyKM7:TR?= NVS2dIVTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
OVCAR-3 NWjodogxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmTvTWM2OD1|Nj6yNFQ2KM7:TR?= M{LqclxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
MOLT-4 MmPVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFPvWY9KSzVyPUO2MlIzQTRizszN M4LvW|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
CAPAN-1 NVi2b3NvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmK4TWM2OD1|Nj60Olk6KM7:TR?= Mlr6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
SCC-9 M370Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2DtSmlEPTB;M{euOFAzPyEQvF2= NWrWPYI1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
SF268 NX7kcZZ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHLMWmdKSzVyPUO4MlM1OzNizszN MlrjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
HGC-27 MnTnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUjJR|UxRTN6LkO3NVEh|ryP MlrGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
DOHH-2 MnH4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVzJR|UxRTN6LkexOVgh|ryP NYP5R5NzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
KE-37 NH;6VFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUDJR|UxRTN6Lkm4Nlgh|ryP MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
MOLT-13 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3nlR2lEPTB;M{muNlUxOiEQvF2= NH:1eYY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
ES1 MnTNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4HGemlEPTB;M{muN|g2KM7:TR?= MojGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
SK-OV-3 MlK5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVrNbIJYUUN3ME2zPU46PjR|IN88US=> M2\kPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
SNU-449 NX7MemZKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{HlNmlEPTB;NECuNFc3PCEQvF2= NVuw[Ig{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
KYSE-510 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFvIVWtKSzVyPUSwMlEzQTVizszN NHfz[4Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
HL-60 NF3EN4NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYTPUnI{UUN3ME20NE46Pzh|IN88US=> NWe1TWp5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
DJM-1 MmH6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVnGeolbUUN3ME20NE46Pzl7IN88US=> NH7BXlQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
TGBC11TKB M1jNVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NW\xUoIzUUN3ME20NU4xQTJ4IN88US=> NXXjXmJ3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
U-2-OS MlzNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoXmTWM2OD12Mj6yOlQyKM7:TR?= MoDJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
NCI-H2030 M1WyNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3f6[WlEPTB;NEKuOFM3QCEQvF2= NHnTN4Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
LU-135 M{LXfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoXSTWM2OD12Mj61OFQ4KM7:TR?= MmK5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
ZR-75-30 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWD0fHlbUUN3ME20N{4xPDl|IN88US=> MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
GT3TKB MnHkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M33FemlEPTB;NEOuNlY4QSEQvF2= NYHNXG9{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
RPMI-2650 NE\wTZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVLJR|UxRTR|Lke4NVYh|ryP M4LTflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
SAS MoDwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlK1TWM2OD12Mz65OVM1KM7:TR?= NUK1TZJTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
MDA-MB-231 MmDzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkH2TWM2OD12Mz65OlA6KM7:TR?= M3PrZ|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
JVM-3 MlLGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkC4TWM2OD12ND6wOVM{KM7:TR?= M1zLOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
COLO-320-HSR NX;4NIM6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoDZTWM2OD12ND61OlM{KM7:TR?= M3zPO|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
SNB75 M37UeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIDLcXpKSzVyPUS0MlYyODVizszN MkDoQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
NCI-H441 M2HROWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUHJR|UxRTR2LkmzNlgh|ryP NVq5eYZNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
HCT-116 NEHVU2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV72V2pYUUN3ME20OE46QDZ6IN88US=> NGjtVHI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NCI-H226 NFyxWlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MW\JR|UxRTR3Lk[zOlgh|ryP MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
CAL-33 M2S4Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4fJSWlEPTB;NEWuPVIyPyEQvF2= Ml3XQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
NCI-H1437 NELKdWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYjJR|UxRTR4LkOyNUDPxE1? NWe1OFVNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
HCC1187 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUPJR|UxRTR4LkSyOVUh|ryP NXn5PWk4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
NUGC-3 M4HkeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFzwTJpKSzVyPUS2MlU4ODlizszN MnfqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
T98G MkDVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVW4S5FZUUN3ME20O{42PDdizszN MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
OVCAR-8 MnjtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M360W2lEPTB;NEeuOlg{KM7:TR?= M1HUelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
LB2241-RCC MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{S2V2lEPTB;NEeuO|I4KM7:TR?= NVXtPFJQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTh7NUi0M{c,W0GQR1XSQE9iRg>?
NCI-H358 NYTIO5g4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MY\JR|UxRTR6LkGxOVIh|ryP MoTLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVg6PTh2Lze+V2FPT0WUPD;hQi=>
PANC-08-13 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1HCeWlEPTB;NEiuNVg2OyEQvF2= M{nqZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE5QTV6ND:nQnNCVkeHUkyvZV4>
KP-N-YN NEjRemhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWHSPYtrUUN3ME20PE4zOTB{IN88US=> MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxPFk2QDRxJ{7TRW5ITVJ:L3G+
NCI-H1755 M4HGeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYfJR|UxRTR6LkK3NlYh|ryP NIrxfIc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
NCI-N87 Mmi4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV7JR|UxRTR6LkK5PVEh|ryP NFzZVWY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyQDl3OESvK|5USU6JRWK8M4E,
SUM52 MXfBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M1rocVUh\GG7cx?= NH7UbXFCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF\HSnIzNWGvcHzp[olm\CCVVV21NkBk\WyuczDh[pRmeiB3IHThfZMh[nliU2LCJIF{e2G7LDDJR|UxKD1iMD6wNVI{KM7:TT6= M3XvVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NUKxNVU3Lz5{OEWyNVE2PjxxYU6=
RT112 M2\VTmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 M2nxc|czKGi{cx?= MmriRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCUVEGxNkBk\WyuczDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDHTVUxKD1iMD6wNVUh|ryPLh?= NHTXVpc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{W5PVc1Oid-Mke1PVk4PDJ:L3G+
insect cells MU\GeY5kfGmxbjDhd5NigQ>? NWjTeodIOTBibXnudy=> NVLlclNjUW6qaXLpeIlwdiCxZjDy[YNwdWKrbnHueEBnfWyuIHzlcod1cCCqdX3hckBHT0[UMTDlfJBz\XO|ZXSgbY4h[mGldXzveolzfXNiaX7m[YN1\WRiaX7z[YN1KGOnbHzzJIlvKHC{ZYPlcoNmKG:oIGvnZY1u[S1|MmDdRXRRKGGodHXyJFExKG2rboOgZpkhe2OrboTpcIxifGmxbjDjc5VvfGmwZzDiZZNm\CC{YXTpc4FkfGm4ZTDmbYx1\XJiYnnu[Ilv\yCjc4PhfUwhUUN3MDC9JFAvODJzNTFOwG0v MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzlzNEO2Nkc,Ojd7MUSzOlI9N2F-
SW780 MoLmRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NY\EcFVDPSCmYYnz M4rpb2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iRlfGVlMu[W2ybHnmbYVlKFOZN{iwJINmdGy|IHHmeIVzKDViZHH5d{BjgSCVUlKgZZN{[XluIFnDOVAhRSByLkC4OFMh|ryPLh?= MljJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh3MkGxOVYoRjJ6NUKxNVU3RC:jPh?=
NIH/ 3T3 MkL2SpVv[3Srb36gZZN{[Xl? M4r4WlUhdWmwcx?= M1Lvd2lvcGmkaYTpc44hd2ZiVlXHSnIzKCi3bnvuc5dvKG:{aXfpckkhd3[ncnX4dJJme3OnZDDpckBud3W|ZTDOTWgwKDOWMzDj[YxteyCrbnP1ZoF1\WRiZn;yJFUhdWmwczDmc4xtd3enZDDifUB{fGmvdXzheIlwdiC5aYToJHZGT0ZiZn;yJFUhdWmwczDifUBqdW23bn;icI91fGmwZzDhcoFtgXOrczygTWM2OCB;IECuNUDPxE1w MoD3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd|Mk[zN|koRjJ5M{K2N|M6RC:jPh?=
NCI-H520 MWTBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M1rmWlch\GG7cx?= M{HKSGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iRlfGVlEu[W2ybHnmbYVlKE6FST3IOVIxKGOnbHzzJIFnfGW{IEeg[IF6eyCkeTDTVmIh[XO|YYmsJGlEPTBiPTCwMlI5OSEQvF2u M37UdlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NUKxNVU3Lz5{OEWyNVE2PjxxYU6=
HUVEC NWjUfHRiTnWwY4Tpc44h[XO|YYm= Mn7XNVAhdk1? MnjMNVQhcHK| MV;Jcohq[mm2aX;uJI9nKE[JRmKtcYVlcWG2ZXSgZY5ocW:pZX7ld4l{KGmwIHj1cYFvKEiXVlXDJINmdGy|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKGOjcHnscIFzgSC2dXLlJJNxem:3dHnu[{BifCBzMDDuUUBi\nSncjCxOEBpenN? M{HXSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF4NEe0N|g4Lz5zNkS3OFM5PzxxYU6=
HUVEC Mk\tSpVv[3Srb36gZZN{[Xl? NH2wS|IyODBibl2= NUfpSJdzOTRiaILz NH63eJRKdmirYnn0bY9vKG:oIF\HSnIudWWmaXH0[YQh[W6paX;n[Y5me2m|IHnuJIh2dWGwIFjVWmVEKGOnbHzzJIF{e2W|c3XkJIF{KGSnY4LlZZNmKGmwIHPhdIltdGG{eTD0eYJmKHOycn;1eIlv\yCjdDCxNFAhdk1iYX\0[ZIhOTRiaILz MmjoQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTZ2N{SzPFcoRjF4NEe0N|g4RC:jPh?=
SJ-GBM2 M2\iO5FJXFNiYYPzZZk> MnLXdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFOMLVfCUVIh[2WubIO= MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
A673 NFvEVZdyUFSVIHHzd4F6 NXPqe2hCeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFG2O|Mh[2WubIO= MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
SK-N-MC MUHxTHRUKGG|c3H5 MoHkdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFONLV6tUWMh[2WubIO= NVjXT2txRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
BT-37 M3yxd5FJXFNiYYPzZZk> NX71fFN6eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFLUMVM4KGOnbHzz NGKxT2Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SK-N-SH M3zNSZFJXFNiYYPzZZk> MX7xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3TTEBk\Wyucx?= NXXSdVRsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
LAN-5 M4XJXZFJXFNiYYPzZZk> MYjxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhVEGQLUWgZ4VtdHN? NHTwc5k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
BT-12 M2DzNpFJXFNiYYPzZZk> MnuwdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEKWLUGyJINmdGy| NVrhbW9RRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh18 Mn;xdWhVWyCjc4PhfS=> NXjqW5M2eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGLoNVgh[2WubIO= M{PZWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
OHS-50 MoXZdWhVWyCjc4PhfS=> M1fiZ5FJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCRSGOtOVAh[2WubIO= M17PXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
RD MV;xTHRUKGG|c3H5 Ml:xdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFKGIHPlcIx{ MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
fibroblast cells NEDqW25yUFSVIHHzd4F6 M2PueZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiClb370do9tKEiqIIfpcIQhfHmyZTDmbYJzd2KuYYP0JINmdGy| M3zKWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Rh41 MlLGdWhVWyCjc4PhfS=> MWjxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWmh2MTDj[Yxtew>? NUTUdmJDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
pFGFR2 / FGFR2 ; 

PubMed: 24968263     


PD173074 and MK2461 inhibit FGFR2 phosphorylation. Cells were treated for 1 hour with a titration of PD173074 as described in Materials and methods. Lysates were prepared and 50 ug protein was subjected to SDS-PAGE and western blotting with phospho Y653/654 FGFR and MAB6841 total FGFR2 antibody.

p-S6RP / p-PRAS40 / p-p105 NFKB / P105 NFKB / P50 NFKB / p-AMPK / p-CRK II / p-PDK1; 

PubMed: 24968263     


Time course of inhibition for multiple signaling proteins. NCI-H716 cells were treated with 100 nM PD173074 for the indicated times and signaling pathways were analyzed by SDS PAGE and western blotting. 100 nM PD173074 was selected because this amount caused full inhibition of pERK at the 2 hour time point. “p” indicates phosphoprotein, and the phosphorylation sites are listed in Methods. Terminology on the right side of figure groups proteins according to the time at which inhibition or protein loss occurs.

24968263
Growth inhibition assay
Cell viability; 

PubMed: 24968263     


B. PD173074 and MK2461 inhibit NCI-H716 cell growth. Cell lines were plated at 4000 cells/well and incubated overnight. NCI-H716 cells were treated with a titration of PD173074 as described in Materials and Methods. Cell growth was measured with Vialight reagent, and growth was presented relative to untreated cells. C. PD173074 and MK2461 selectively inhibit growth of NCI-H716 cells. Colon cancer cell lines listed were plated at 4000 cells/well and 24 hours later were treated with a titration of compounds. 4 days later cell growth was measured with vialight and IC50s were calculated from graph pad prism. 

24968263
In vivo Administration of PD173074 at 1 mg/kg/day or 2 mg/ka/day in mice can effectively block angiogenesis induced by either FGF or VEGF in a dose-dependent manner with no apparent toxicity. [1] PD173074 inhibits in vivo growth of mutant FGFR3-transfected NIH 3T3 cells in nude mice. Inhibition of FGFR3 by PD173074 delays tumor growth and increases survival of mice in a KMS11 xenograft myeloma model. [4] In the H-510 xenograft, oral aministration of PD173074 blocks tumor growth similar to that seen with single-agent cisplatin administration, increasing median survival compared with control sham-treated animals. In H-69 xenografts, PD173074 induces complete responses lasting >6 months in 50% of mice. These effects are correlated with increased apoptosis in excised tumors, but not a consequence of disrupted tumor vasculature. [5]

Protocol

Kinase Assay:[1]
- Collapse

In vitro kinase inhibition assays:

Assays using the full-length FGFR-1 kinase are performed in a total volume of 100 μL containing 25 mM HEPES buffer (pH 7.4), 150 mM NaCl, 10 mM MnCl2, 0.2 mM sodium orthovanadate, 750 μg/mL concentration of a random copolymer of glutamic acid and tyrosine (4:1), various concentrations of PD173074 and 60 to 75 ng of enzyme. The reaction is initiated by the addition of [γ-32P]ATP (5 μM ATP containing 0.4 μCi of [γ-32P]ATP per incubation), and samples are incubated at 25°C for 10 minutes. The reaction is terminated by the addition of 30% trichloroacetic acid and the precipitation of material onto glass-fiber filter mats. Filters are washed three times with 15% trichloroacetic acid, and the incorporation of [32P] into the glutamate tyrosine polymer substrate is determined by counting the radioactivity retained on the filters in a Wallac 1250 betaplate reader. Nonspecific activity is defined as radioactivity retained on the filters following incubation of samples without enzyme. Specific activity is determined as total activity (enzyme plus buffer) minus nonspecific activity. The concentration of PD173074 that inhibits FGFR-1 enzymatic activity by 50% (IC50) is determined graphically.
Cell Research:[4]
- Collapse
  • Cell lines: KMS11 and KMS18
  • Concentrations: Dissolved in DMSO, final concentrations ~100 nM
  • Incubation Time: 48 hours
  • Method: Cells are incubated with increasing concentrations of PD173074 in the presence of aFGF/heparin for 48 hours. The percentage of viable cells is determined by MTT.
    (Only for Reference)
Animal Research:[1]
- Collapse
  • Animal Models: Swiss Webster mice with induced corneal angiogenesis
  • Dosages: ~2 mg/kg/day
  • Administration: Administered intraperitoneally
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 100 mg/mL (190.95 mM)
Ethanol 100 mg/mL (190.95 mM)
Water Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
5% DMSO+corn oil
For best results, use promptly after mixing.
15mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 523.67
Formula

C28H41N7O3

CAS No. 219580-11-7
Storage powder
in solvent
Synonyms N/A
Smiles CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    What is the half-life of PD173074(S1264) in vivo?

  • Answer:

    According to literature research, PD173074 is given twice daily because it has a short half-life in vivo, please refer to the following link for detailed pharmacokinetic information (Supplementary Figure 8B): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990281/#!po=50.0000.

FGFR Signaling Pathway Map

FGFR Inhibitors with Unique Features

Related FGFR Products

Tags: buy PD173074 | PD173074 supplier | purchase PD173074 | PD173074 cost | PD173074 manufacturer | order PD173074 | PD173074 distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID